{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:43:09Z","timestamp":1794328989568,"version":"4.9.0"},"reference-count":68,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>The association between nonalcoholic fatty liver disease (NAFLD) with cardiovascular and cerebrovascular outcomes, as well as their clinical impact, has yet to be established in the literature. This meta-analysis aims to evaluate the association between the NAFLD patients and the risk of atrial fibrillation (AF), heart failure (HF), stroke, cardiovascular mortality (CVM), and revascularization incidence. We performed a systematic literature search using PubMed, Embase, Scopus, and Cochrane libraries for relevant articles from inception until August 2022. A total of 12 cohort studies with 18,055,072 patients (2,938,753 NAFLD vs 15,116,319 non-NAFLD) were included in our analysis. The mean age of the NAFLD patients group and the non-NAFLD group was comparable (55.68 vs 55.87). The most common comorbidities among the NAFLD patients group included hypertension (38% vs 24%) and diabetes mellitus (14% vs 8%). The mean follow-up duration was 6.26\u2009years. The likelihood of AF (risk ratio (RR), 1.42 (95% CI 1.19, 1.68), p\u2009&lt;\u20090.001), HF (RR, 1.43(95% CI 1.03, 2.00), p\u2009&lt;\u20090.001), stroke (RR, 1.26(95% CI 1.16, 1.36), p\u2009&lt;\u20090.001), revascularization (RR, 4.06(95% CI 1.44, 11.46), p\u2009=\u20090.01), and CVM (RR, 3.10(95% CI 1.43, 6.73), p\u2009&lt;\u20090.001) was significantly higher in the NAFLD patients group compared to that of the non-NAFLD group. However, all-cause mortality was comparable between both the groups of patients (RR, 1.30 (95% CI 0.63, 2.67), p\u2009=\u20090.48). In conclusion, the patients with NAFLD are at increased risk of AF, HF, and CVM.<\/jats:p>","DOI":"10.1177\/10815589231164777","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T02:56:37Z","timestamp":1680317797000},"page":"591-602","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis"],"prefix":"10.1177","volume":"71","author":[{"given":"Vikash","family":"Jaiswal","sequence":"first","affiliation":[{"name":"JCCR Cardiology, Varanasi, Uttar Pradesh, India"},{"name":"Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Peng","family":"Ang","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Rutgers Health\/Community Medical Center, Toms River, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Huang","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navroop Kaur","family":"Momi","sequence":"additional","affiliation":[{"name":"Christian Medical College and Hospital, Ludhiana, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Hameed","sequence":"additional","affiliation":[{"name":"Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Naz","sequence":"additional","affiliation":[{"name":"The University of Texas, MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitya","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Beaumont Hospital, Royal Oak, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ishak","sequence":"additional","affiliation":[{"name":"Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel","family":"Doshi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pravara Institute of Medical Science, Ahmednagar, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Gera","sequence":"additional","affiliation":[{"name":"Department of Research and Academic Affairs, Larkin Community Hospital, South Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Sharath","sequence":"additional","affiliation":[{"name":"Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeeha Subhan","family":"Waleed","sequence":"additional","affiliation":[{"name":"Lower Bucks Hospital, Bristol, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishchita","family":"Raj","sequence":"additional","affiliation":[{"name":"JCCR Cardiology, Varanasi, Uttar Pradesh, India"},{"name":"B.P Koirala Institute of Health Science, Dharan, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Hugo","family":"Aguilera Alvarez","sequence":"additional","affiliation":[{"name":"Autonomous University of Baja California, Mexicali, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00165-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29466"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26156"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.038"},{"key":"e_1_3_2_8_2","first-page":"42","article-title":"Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Raza S","year":"2019","unstructured":"Raza S, Rajak S, Anjum B, et al. Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma. Hepatoma Res 2019; 5: 42.","journal-title":"Hepatoma Res"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.11.039"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1381\/0960892053576820"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2015.08.004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.005"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83367-x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320622"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05986-9"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030433"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005227"},{"key":"e_1_3_2_18_2","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","author":"Alexander M","unstructured":"Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. Epub ahead of print 8 October 2019. DOI: 10.1136\/bmj.l5367.","journal-title":"BMJ"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.101019"},{"key":"e_1_3_2_20_2","article-title":"Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis","author":"Jaiswal V","unstructured":"Jaiswal V, Ang SP, Yaqoob S, et al. Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis. Eur J Prev Cardiol. Epub ahead of print 20 July 2022. DOI: 10.1093\/eurjpc\/zwac152.","journal-title":"Eur J Prev Cardiol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2022.101125"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2023.101170"},{"key":"e_1_3_2_23_2","unstructured":"Wells G Shea B O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (accessed 23 February 2022)."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000401"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.12.026"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01192-4"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014279"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142937"},{"key":"e_1_3_2_32_2","article-title":"Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank","volume":"13","author":"Ma W","year":"2022","unstructured":"Ma W, Wu W, Wen W, et al. Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank. Ther Adv Chron Dis 2022; 13: 204062232211224.","journal-title":"Ther Adv Chron Dis"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.01.070"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.34172\/mejdd.2022.270"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61750-4"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.832023"},{"key":"e_1_3_2_38_2","article-title":"Glutamyltransferase and risk of stroke: the EUROSTROKE project","volume":"56","author":"Bots ML","year":"2002","unstructured":"Bots ML, Salonen JT, Elwood PC, et al. Glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health 2002; 56(suppl. 1): i25\u2013i29.","journal-title":"J Epidemiol Community Health"},{"key":"e_1_3_2_39_2","article-title":"Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals","author":"Mantovani A","unstructured":"Mantovani A, Petracca G, Csermely A, et al. Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut. Epub ahead of print 25 July 2022. DOI: 10.1136\/gutjnl-2022-327672.","journal-title":"Gut"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.007241"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211047074"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01374-8"},{"key":"e_1_3_2_43_2","article-title":"Risk of cardiovascular disease and loss in life expectancy in NAFLD","author":"Shang Y","unstructured":"Shang Y, Nasr P, Widman L, et al. Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology. Epub ahead of print 23 April 2022. DOI:10.1002\/hep.32519.","journal-title":"Hepatology"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01792-9"},{"issue":"4","key":"e_1_3_2_45_2","first-page":"217","article-title":"Peripheral artery disease and risk of fibrosis deterioration in nonalcoholic fatty liver disease: a prospective investigation","volume":"33","author":"Zhu W","year":"2020","unstructured":"Zhu W, Deng CJ, Xuan LP, et al. Peripheral artery disease and risk of fibrosis deterioration in nonalcoholic fatty liver disease: a prospective investigation. Biomed Environ Sci 2020; 33(4): 217\u2013226.","journal-title":"Biomed Environ Sci"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2016.12.033"},{"issue":"3","key":"e_1_3_2_47_2","first-page":"258","article-title":"Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis","volume":"10","author":"Khalid YS","year":"2020","unstructured":"Khalid YS, Dasu NR, Suga H, et al. Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. Am J Cardiovasc Dis 2020; 10(3): 258\u2013271.","journal-title":"Am J Cardiovasc Dis"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.10.007"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47687-3"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.2462"},{"key":"e_1_3_2_51_2","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Ha J","unstructured":"Ha J, Yim SY, Karagozian R. Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. Epub ahead of print 26 November 2022. DOI: 10.1016\/j.cgh.2022.11.019.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024557"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8407"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000532"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0513"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413529"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13344"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006558"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-015-1001-5"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162511"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2017.343"},{"issue":"11","key":"e_1_3_2_62_2","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al. 2019ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation 2019; 140(11): e563\u2013e595.","journal-title":"Circulation"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0860-y"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2012.11.003"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e318239b924"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21171"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00891-0"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708959"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01558-w"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589231164777","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10815589231164777","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589231164777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:12:03Z","timestamp":1779945123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10815589231164777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1177\/10815589231164777"],"URL":"https:\/\/doi.org\/10.1177\/10815589231164777","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}